URPL: Announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products concerning conveying applications regarding serious adverse reaction of medicinal products from Office for Registration to MAH.
28.11.2013
This document is an announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products concerning conveying applications regarding serious adverse reaction of medicinal products from Office for Registration to MAH.
SciencePharma
